Definium Therapeutics, Inc.

NASDAQ:DFTX

Biotechnology

Healthcare
$29.12 -1.67%

-$0.41 today

Market cap
$3.99B
Beta
2.38
P/E (TTM)
-11.0
EPS (TTM)
-$2.18
52W Low $12.88High $26.15

Volume 1.91M

Average 2.67M

Balance Sheet

Inspect the capital base behind the business.

Assets

$440.10M

FY 2025 · Annual

+45.7% YoY

Liabilities

$107.77M

FY 2025 · Annual

+77.5% YoY

Equity

$332.33M

FY 2025 · Annual

+37.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents133.54M142.14M99.7M273.74M257.84M
Short-term Investments0000153.76M
Net Receivables00000
Inventory00000
Other Current Assets004.17M7.88M7.73M
Total Current Assets137.22M146.06M103.87M281.62M419.32M
Property, Plant & Equipment (Net)00000
Goodwill19.92M19.92M19.92M19.92M19.92M
Intangible Assets6.87M3.69M527K00
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0331K224K613K862K
Total Non-current Assets26.79M23.94M20.67M20.53M20.78M
Total Assets164M169.99M124.54M302.15M440.1M
Account Payables4.18M2.11M4.14M2.01M5.35M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.3M13.03M20.74M30.42M61.35M
Total Current Liabilities10.41M17.89M32.25M38.85M66.7M
Long-term Debt0014.13M21.85M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.93M1.18M32K041.08M
Total Non-current Liabilities1.93M1.18M14.16M21.85M41.08M
Total Liabilities12.34M19.08M46.41M60.7M107.77M
Common Stock00000
Retained Earnings(137.67M)(194.47M)(290.2M)(398.88M)(582.67M)
Accumulated OCI1.05M627K343K819K1.09M
Other Stockholders Equity00000
Minority Interest00000
Total Equity151.66M150.92M78.13M241.45M332.33M
Total Debt072K14.13M21.85M0
Net Debt(133.54M)(142.07M)(85.58M)(251.89M)(257.84M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$241.2M
Short-term Investments$805.7M
Other Current$4.9M
Total Current Assets$1.1B
Goodwill$19.9M
Other Non-current$2.6M
Total Non-current Assets$22.5M
Total Assets$1.1B

Analysis

Selected assets total $1.1B for Latest. The largest visible component is Short-term Investments at $805.7M, about 75.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13GSC 13G filingNov 5, 2026
4Statement of changes in beneficial ownershipSep 29, 2026

How much cash does DFTX have?

Definium Therapeutics, Inc. (DFTX) reported $257.84M in cash and equivalents in fiscal 2025.

How much debt does DFTX carry?

Definium Therapeutics, Inc. (DFTX) reported $0.00 of total debt, with net debt of -$257.84M.